Hypermetabolism in patients with dementia with Lewy bodies

Clinical Nuclear Medicine

Volumn 35, Issue 7, 2010, Pages 490-493

  Miyazawa, Nobuhiko ^a   Shinohara, Toyoaki ^a   Nagasaka, Takamura ^b   Hayashi, Masataka ^c  

^a Department of PET Center of Kofu Neurosurgical Hospital ^*  (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c Kofu Municipal Hospital   (Japan)

Author keywords

brain FDG PET; hypermetabolism; Lewy body dementia

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASSOCIATION; BASAL GANGLION; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; HYPERMETABOLISM; MALE; MOTOR CORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; CEREBELLUM; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 77954011299     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181e05dbc     Document Type: Article

References (22)

1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guideline for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
2. Perry RH, Irving D, Blessed G, et al. Senile dementia of Lewy body type: a clinically and pathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci. 1990;95:119-139.
3. Simard M, van Reekum R. The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci. 2004;16:409-425.
4. Shimizu S, Hanyu H, Hirao K, et al. Value of analyzing deep gray matter and occipital lobe perfusion to differentiate dementia with Lewy bodies from Alzheimer's disease. Ann Nucl Med. 2008;22:911-916.
5. Ishii K, Yamaji S, Kitagaki H, et al. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology. 1999;53:413-416. (Pubitemid 29344372)
6. Pasquier J, Michel B, Breno-Rossi I, et al. Value of (99 m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2002;29:1342-1348.
7. Albin RL, Minoshima S, D'Amato CJ, et al. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 1996;47: 462-466.
8. Imamura T, Ishii K, Sasaki M, et al. Regional cerebral glucose metabolism in dementia comparative study using positron emission tomography. Neurosci Lett. 1997;235:49-52.
9. Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology. 1998;51: 125-130. (Pubitemid 28345371)
10. Higuchi M, Tashiro M, Arai H, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol. 2000;162:247-256.
11. Minoshima S, Foster NL, Sima AAF, et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50:358-365.
12. Sato T, Hanyu K, Hirao S, et al. Deep gray matter hyperperfusion with occipital hypoperfusion in dementia with Lewy bodies. Eur J Neurol. 2007; 14:1299-1301.
13. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology. 2001;56:643-649.
14. Donnemiller E, Heilmann J, Wenning G, et al. Brain perfusion scintigraphy with (99 m)Tc-HMPAO or (99 m)Tc-ECD and (123)I-β-CIT single-photon emission tomography in dementia of Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med. 1997;24:320-325.
15. McKeith IG, Dickson DW, Lowe J, et al. Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for clinician. J Psychiatr Res. 1975;12:189-198.
17. Minoshima S, Koeppe RA, Frey KA, et al. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35:1528-1537.
18. Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG-PET. J Nucl Med. 1995;36:1238-1248.
19. Imamura T, Ishii K, Hirono N, et al. Visual hallucinations and cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport. 1999;10: 1903-1907. (Pubitemid 29331747)
20. Silbersweig DA, Stem E, Frith C, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 1995;378:176-179.
21. Knopman DS, Dekosky ST, Cummings JL, et al. Practical parameter: diagnosis of dementia (an evidence-based review), report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2001;56: 1143-1153.
22. Mckeith IG, Ballard CG, Perry RH, et al. Pronive validation of consensus criteria for diagnosis of dementia with Lewy bodies. Neurology. 2000;54: 1050-1058.